These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 21732299)

  • 61. Statins for people with diabetes.
    Cheung BM
    Lancet; 2008 Jan; 371(9607):94-5. PubMed ID: 18191668
    [No Abstract]   [Full Text] [Related]  

  • 62. Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients: a French adaptation of CARDS.
    Lafuma A; Colin X; Solesse A
    Arch Cardiovasc Dis; 2008 May; 101(5):327-32. PubMed ID: 18656091
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Integrating economic analysis into clinical trials.
    Imai K; Zhang P
    Lancet; 2005 May 21-27; 365(9473):1749-50. PubMed ID: 15910936
    [No Abstract]   [Full Text] [Related]  

  • 64. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Statins for Primary Prevention in Adults Aged 75 Years or Older.
    Robinson JG
    Ann Intern Med; 2015 Sep; 163(6):481. PubMed ID: 26370013
    [No Abstract]   [Full Text] [Related]  

  • 66. Statins for Primary Prevention in Adults Aged 75 Years or Older.
    Reidenberg MM
    Ann Intern Med; 2015 Sep; 163(6):481. PubMed ID: 26370014
    [No Abstract]   [Full Text] [Related]  

  • 67. Statins for Primary Prevention in Adults Aged 75 Years or Older.
    Odden MC; Goldman L; Bibbins-Domingo K
    Ann Intern Med; 2015 Sep; 163(6):482. PubMed ID: 26370015
    [No Abstract]   [Full Text] [Related]  

  • 68. Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials.
    Navaneethan SD; Pansini F; Strippoli GF
    PLoS Med; 2006 May; 3(5):e123. PubMed ID: 16719546
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Correction: cost-effectiveness of statins in older patients with myocardial infarction.
    Ganz DA; Kuntz KM; Benner JS; Avorn J
    Ann Intern Med; 2002 Apr; 136(8):635. PubMed ID: 11955042
    [No Abstract]   [Full Text] [Related]  

  • 70. Cost-effectiveness analyses.
    Clark CM
    Ann Intern Med; 2001 Sep; 135(5):382-3. PubMed ID: 11529708
    [No Abstract]   [Full Text] [Related]  

  • 71. The cost-effectiveness of drug treatments for primary prevention of cardiovascular disease: a modelling study.
    Marshall T
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):523-8. PubMed ID: 16874140
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Appropriate clinical use of statins: a discussion of the evidence, scope, benefits, and risk.
    Perlmutter D; Golomb B; Sinatra S; Campbell AW
    Altern Ther Health Med; 2013; 19 Suppl 1():14-25. PubMed ID: 23981463
    [No Abstract]   [Full Text] [Related]  

  • 73. Statins in Persons at Low Risk of Cardiovascular Disease.
    Abramson J
    Am Fam Physician; 2017 Nov; 96(9):Online. PubMed ID: 29094882
    [No Abstract]   [Full Text] [Related]  

  • 74. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Statins for Primary Prevention of Cardiovascular Disease: Review of Evidence and Recommendations for Clinical Practice.
    Kazi DS; Penko JM; Bibbins-Domingo K
    Med Clin North Am; 2017 Jul; 101(4):689-699. PubMed ID: 28577620
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cholesterol Lowering in 2015: Still Answering Questions About How and in Whom.
    Greenland P; Lauer MS
    JAMA; 2015 Jul; 314(2):127-8. PubMed ID: 26172891
    [No Abstract]   [Full Text] [Related]  

  • 77. [HMG-CoA reductase inhibitors in prevention of cardiovascular diseases: new mechanisms, aspects and trials].
    Wojakowski W; Gmiński J
    Przegl Lek; 2000; 57(5):291-5. PubMed ID: 11057120
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The safety of statins in children.
    Lamaida N; Capuano E; Pinto L; Capuano E; Capuano R; Capuano V
    Acta Paediatr; 2013 Sep; 102(9):857-62. PubMed ID: 23631461
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Formulation of treatment recommendations for statins.
    Huffman MD; Ebrahim S; Dickersin K
    JAMA; 2014 Jan; 311(3):305-6. PubMed ID: 24430328
    [No Abstract]   [Full Text] [Related]  

  • 80. Formulation of treatment recommendations for statins.
    O'Sullivan C; Brown L
    JAMA; 2014 Jan; 311(3):305. PubMed ID: 24430327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.